Pesquisas alternativas:
across developed » cross developed (Expandir a Pesquisa), across development (Expandir a Pesquisa), actions developed (Expandir a Pesquisa)
developed type » developed ptypei (Expandir a Pesquisa), developed thyme (Expandir a Pesquisa), developed time (Expandir a Pesquisa)
model develop » model develops (Expandir a Pesquisa), models develop (Expandir a Pesquisa), model developed (Expandir a Pesquisa)
develop type » developing type (Expandir a Pesquisa)
drug across » drugs across (Expandir a Pesquisa), drug cross (Expandir a Pesquisa), drug access (Expandir a Pesquisa)
drug model » drug models (Expandir a Pesquisa), drug mode (Expandir a Pesquisa), drugs mode (Expandir a Pesquisa)
across developed » cross developed (Expandir a Pesquisa), across development (Expandir a Pesquisa), actions developed (Expandir a Pesquisa)
developed type » developed ptypei (Expandir a Pesquisa), developed thyme (Expandir a Pesquisa), developed time (Expandir a Pesquisa)
model develop » model develops (Expandir a Pesquisa), models develop (Expandir a Pesquisa), model developed (Expandir a Pesquisa)
develop type » developing type (Expandir a Pesquisa)
drug across » drugs across (Expandir a Pesquisa), drug cross (Expandir a Pesquisa), drug access (Expandir a Pesquisa)
drug model » drug models (Expandir a Pesquisa), drug mode (Expandir a Pesquisa), drugs mode (Expandir a Pesquisa)
61
Por Thibeault, Kimberly C., Gunes Kutlu, Munir, Sanders, Christina, Calipari, Erin S.
Publicado no Brain Res (2018)
“...Drug addiction is a major public health concern across the world for which there are limited...”Publicado no Brain Res (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
62
“... have been implicated which impede the development of adequate treatments that work across all patient...”
Obter o texto integral
Obter o texto integral
Artigo
63
Por Lee, Ho-June, Schaefer, Gabriele, Heffron, Timothy P., Shao, Lily, Ye, Xiaofen, Sideris, Steve, Malek, Shiva, Chan, Emily, Merchant, Mark, La, Hank, Ubhayakar, Savita, Yauch, Robert L., Pirazzoli, Valentina, Politi, Katerina, Settleman, Jeff
Publicado em 2012
“... molecule EGFR kinase inhibitors develop drug resistance associated with the EGFR T790M “gatekeeper...”Publicado em 2012
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
64
Por González-Barriga, Anchel, Kranzen, Julia, Croes, Huib J. E., Bijl, Suzanne, van den Broek, Walther J. A. A., van Kessel, Ingeborg D. G., van Engelen, Baziel G. M., van Deutekom, Judith C. T., Wieringa, Bé, Mulders, Susan A. M., Wansink, Derick G.
Publicado no PLoS One (2015)
“...Myotonic Dystrophy type 1 (DM1) is a multisystemic disease caused by toxic RNA from a DMPK gene...”Publicado no PLoS One (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
65
Development of arrayed colonic organoids for screening of secretagogues associated with enterotoxins
Por Gunasekara, Dulan B., DiSalvo, Matthew, Wang, Yuli, Nguyen, Daniel L., Reed, Mark I., Speer, Jennifer, Sims, Christopher E., Magness, Scott T., Allbritton, Nancy L.
Publicado no Anal Chem (2018)
“... ion transport and subsequent water flux in physiology and disease models. In conventional cultures...”Publicado no Anal Chem (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
66
“...Numerous nano drug delivery systems have been developed for preclinical cancer research in the past...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
67
Por Chien, Huan-Chieh, Colas, Claire, Finke, Karissa, Springer, Seth, Stoner, Laura, Zur, Arik A., Venteicher, Brooklynn, Campbell, Jerome, Hall, Colton, Flint, Andrew, Augustyn, Evan, Hernandez, Christopher, Heeren, Nathan, Hansen, Logan, Anthony, Abby, Bauer, Justine, Fotiadis, Dimitrios, Schlessinger, Avner, Giacomini, Kathleen M., Thomas, Allen A.
Publicado no J Med Chem (2018)
“...The L-type amino acid transporter 1 (LAT1, SLC7A5) transports essential amino acids across...”Publicado no J Med Chem (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
68
Por Donnelly, Louise A., Zhou, Kaixin, Doney, Alex S. F., Jennison, Chris, Franks, Paul W., Pearson, Ewan R.
Publicado no Diabetologia (2017)
“... developed a novel approach for modelling the progression of diabetes in observational data across multiple...”Publicado no Diabetologia (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
69
“...<p>Abstract</p> <p>Harm reduction is a controversial model for treating drug users, with little...”
Obter o texto integral
Obter o texto integral
Artigo
70
“...Harm reduction is a controversial model for treating drug users, with little formal research...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
71
Por Vighi, Eleonora, Trifunović, Dragana, Veiga-Crespo, Patricia, Rentsch, Andreas, Hoffmann, Dorit, Sahaboglu, Ayse, Strasser, Torsten, Kulkarni, Manoj, Bertolotti, Evelina, van den Heuvel, Angelique, Peters, Tobias, Reijerkerk, Arie, Euler, Thomas, Ueffing, Marius, Schwede, Frank, Genieser, Hans-Gottfried, Gaillard, Pieter, Marigo, Valeria, Ekström, Per, Paquet-Durand, François
Publicado no Proc Natl Acad Sci U S A (2018)
“... with an innovative drug delivery method may enable a single type of treatment to address genetically divergent RD...”Publicado no Proc Natl Acad Sci U S A (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
72
Por Gillet, Jean-Pierre, Calcagno, Anna Maria, Varma, Sudhir, Marino, Miguel, Green, Lisa J., Vora, Meena I., Patel, Chirayu, Orina, Josiah N., Eliseeva, Tatiana A., Singal, Vineet, Padmanabhan, Raji, Davidson, Ben, Ganapathi, Ram, Sood, Anil K., Rueda, Bo R., Ambudkar, Suresh V., Gottesman, Michael M.
Publicado em 2011
“...Although in vitro models have been a cornerstone of anti-cancer drug development, their direct...”Publicado em 2011
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
73
Por Lin Yang, Shi Zhao, Tsun Kit Chu, Jinxiao Lian, Cheuk Wai Lo, Daihai He, Jing Qin
Publicado em 2020-07-01
“...Objectives This study is aimed to develop and validate a prediction model for multistate...”Publicado em 2020-07-01
Obter o texto integral
Artigo
74
Por Balewgizie Sileshi Tegegne, Melkamu Merid Mengesha, Andreas A. Teferra, Mamaru Ayenew Awoke, Tesfa Dejenie Habtewold
Publicado em 2018-10-01
Assuntos:
“...Multi-drug-resistant tuberculosis...”Publicado em 2018-10-01
Obter o texto integral
Artigo
75
Por Tegegne, Balewgizie Sileshi, Mengesha, Melkamu Merid, Teferra, Andreas A., Awoke, Mamaru Ayenew, Habtewold, Tesfa Dejenie
Publicado no Syst Rev (2018)
“... co-morbidity is associated with a higher risk of developing multi-drug-resistant tuberculosis (MDR-TB...”Publicado no Syst Rev (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
76
Por Smith, Nathan, Martins, Silvia S, Kim, June, Rivera-Aguirre, Ariadne, Fink, David S, Castillo-Carniglia, Alvaro, Henry, Stephen G, Mooney, Stephen J, Marshall, Brandon D.L., Davis, Corey, Cerdá, Magdalena
Publicado no Addiction (2018)
“... study used latent transition analysis to: (1) identify the types of PDMP models that have developed from...”Publicado no Addiction (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
77
Por Schmitt, Michael W., Pritchard, Justin R., Leighow, Scott, Aminov, Bella I., Beppu, Lan, Kim, Daniel S., Hodgson, J. Graeme, Rivera, Victor M., Loeb, Lawrence A., Radich, Jerald P.
Publicado no Clin Cancer Res (2018)
“... of resistance mutations in drug targets. This mutational complexity has spurred the development of pan-target...”Publicado no Clin Cancer Res (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
78
Por Jiang, Ying-Ping, Liu, Bob Y., Zheng, Quan, Panuganti, Swapna, Chen, Ruoying, Zhu, Jianyu, Mishra, Madhavi, Huang, Jianqing, Dao-Pick, Trang, Roy, Sharmili, Zhao, XiaoXian, Lin, Jeffrey, Banik, Gautam, Hsi, Eric D., Mandalam, Ramkumar, Junutula, Jagath R.
Publicado no Blood Adv (2018)
“... healthy organ tissues. Expression of CLL1 was consistent across different types of AML. We developed CLT...”Publicado no Blood Adv (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
79
Por Dorottya Kocsis, Szabina Horváth, Ágnes Kemény, Zsófia Varga-Medveczky, Csaba Pongor, Rózsa Molnár, Anna Mihály, Dániel Farkas, Bese Márton Naszlady, András Fülöp, András Horváth, Balázs Rózsa, Erika Pintér, Rolland Gyulai, Franciska Erdő
Publicado em 2022-04-01
“... showed increased skin permeability for the model drug during disease progression. In wild type and TRPA1...”Publicado em 2022-04-01
Obter o texto integral
Artigo
80
Por Khan Suleiman A, Faisal Ali, Mpindi John, Parkkinen Juuso A, Kalliokoski Tuomo, Poso Antti, Kallioniemi Olli P, Wennerberg Krister, Kaski Samuel
Publicado em 2012-05-01
“... with these drugs. Importantly, the analysis focused on chemical-biological properties that emerge across multiple...”Publicado em 2012-05-01
Obter o texto integral
Artigo